PMDA drug package insert
アクプラ静注用10mg
PMDA Prescription drug · 日医工株式会社 · package insert Jun 17, 2022
Key facts
| Brand names | アクプラ静注用10mg, アクプラ静注用50mg, アクプラ静注用100mg |
|---|---|
| Nonproprietary names | ネダプラチン |
| Companies | 製造販売元／日医工株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291405F1025, 4291405F2021, 4291405F3028 |
| Approval numbers | 20700AMZ00529000, 20700AMZ00531000, 20700AMZ00533000 |
| Package insert edition | 第1版 |
| Package insert date | Jun 17, 2022 |
| PMDA document key | 530169_4291405F1025_2 |
| PMDA company code | 530169 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: